In Phase A, participants will obtain distinctive doses and schedules of oral ABBV-744 tablet to recognize safe dosing routine. Additional individuals is going to be enrolled at the recognized monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 will likely be supplied as "incorporate-on" therapy. In https://antoniol776zkv9.sasugawiki.com/user